Bayer: urgent need for patent term extension in China
Jörg Thomaier, head of IP at Bayer, explains why PTE will help the pharma industry and what an ideal patent linkage system looks like
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: